INTEGER HOLDINGS CORPORATION (ITGR) Gross Margin
- Gross margin · 12 months: Value 25.68%; Formula and calculation Gross profit / revenue. Period ending 2026-07-03..
Gross margin
Overview →Financial period ending 2026-07-03; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | 25.68% | Gross profit / revenue. Period ending 2026-07-03. $473.45M ÷ $1.84B × 100 ≈ 25.68% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | 473.45M USD | Gross Profit |
| Revenue | 1.84B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | 1.37B USD | Cost of Goods and Services Sold |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2026-07-03 | $473.45M | $1.84B | $1.37B | 25.68% |
| 2026-04-03 | $489.66M | $1.86B | $1.37B | 26.39% |
| 2025-12-31 | $500.39M | $1.85B | $1.35B | 26.99% |
| 2025-09-26 | $492.43M | $1.83B | $1.34B | 26.89% |
| 2025-06-27 | $482.83M | $1.79B | $1.31B | 26.90% |
| 2025-03-28 | $471.06M | $1.75B | $1.28B | 26.98% |
| 2024-12-31 | $459.01M | $1.72B | $1.26B | 26.74% |
| 2024-09-27 | $460.18M | $1.71B | $1.25B | 26.87% |
| 2024-06-28 | $445.05M | $1.67B | $1.22B | 26.67% |
| 2024-03-29 | $431.46M | $1.63B | $1.20B | 26.43% |
| 2023-12-31 | $418.29M | $1.60B | $1.18B | 26.20% |
| 2023-09-29 | $405.95M | $1.56B | $1.15B | 26.09% |
| 2023-06-30 | $387.11M | $1.49B | $1.11B | 25.91% |
| 2023-03-31 | $374.20M | $1.44B | $1.07B | 25.91% |
| 2022-12-31 | $359.01M | $1.38B | $1.02B | 26.09% |
| 2022-09-30 | $342.96M | $1.32B | $973.73M | 26.05% |
| 2022-07-01 | $338.11M | $1.28B | $941.47M | 26.42% |
| 2022-04-01 | $333.96M | $1.24B | $907.57M | 26.90% |
| 2021-12-31 | $336.97M | $1.22B | $884.11M | 27.60% |
| 2021-10-01 | $328.31M | $1.18B | $848.71M | 27.89% |
| 2021-07-02 | $304.37M | $1.11B | $803.02M | 27.49% |
| 2021-04-02 | (m) | (m) | $761.99M | (m) |
| 2020-12-31 | $285.71M | $1.07B | $787.74M | 26.62% |
| 2020-10-02 | $288.53M | $1.13B | $841.59M | 25.53% |
| 2020-07-03 | $323.98M | $1.20B | $873.78M | 27.05% |
| 2020-04-04 | $363.10M | $1.27B | (m) | 28.55% |
| 2020-04-03 | $363.10M | $1.27B | $908.74M | 28.55% |
| 2019-12-31 | $355.01M | $1.26B | $903.08M | 28.22% |
| 2019-09-27 | $367.43M | $1.24B | $868.07M | 29.74% |
| 2019-06-28 | $365.96M | $1.24B | $871.03M | 29.58% |
| 2019-03-29 | $367.74M | $1.24B | $869.52M | 29.72% |
| 2018-12-28 | $362.67M | $1.22B | $852.35M | 29.85% |
| 2018-09-28 | $407.38M | $1.54B | $1.13B | 26.45% |
| 2018-06-29 | $404.64M | $1.52B | $1.12B | 26.60% |
| 2018-03-30 | $398.10M | $1.50B | $1.10B | 26.57% |
| 2017-12-29 | $393.55M | $1.46B | $1.07B | 26.92% |
| 2017-09-29 | $381.62M | $1.43B | $1.05B | 26.67% |
| 2017-06-30 | $381.30M | $1.41B | $1.03B | 26.96% |
| 2017-03-31 | $378.06M | $1.40B | $1.02B | 27.00% |
| 2016-12-30 | $378.30M | $1.39B | $1.01B | 27.28% |
| 2016-09-30 | $358.55M | $1.34B | $986.21M | 26.66% |
| 2016-07-01 | $312.29M | $1.14B | $832.54M | 27.28% |
| 2016-04-01 | $274.20M | $971.33M | $697.13M | 28.23% |
| 2016-01-01 | $235.13M | $800.41M | $565.28M | 29.38% |
| 2015-10-02 | $219.21M | $652.57M | $433.36M | 33.59% |
| 2015-07-03 | $225.68M | $677.63M | $451.95M | 33.30% |
| 2015-04-03 | $226.20M | $674.83M | $448.63M | 33.52% |
| 2015-01-02 | $231.40M | $687.79M | $456.39M | 33.64% |
| 2014-10-03 | $231.57M | $694.68M | $463.11M | 33.33% |
| 2014-07-04 | $229.33M | $690.71M | $461.38M | 33.20% |
| 2014-04-04 | $228.16M | $689.96M | $461.80M | 33.07% |
| 2014-01-03 | $219.31M | $663.95M | $444.63M | 33.03% |
| 2013-09-27 | $213.80M | $646.51M | $432.71M | 33.07% |
| 2013-06-28 | $208.88M | $640.12M | $431.24M | 32.63% |
| 2013-03-29 | $203.51M | $635.34M | $431.83M | 32.03% |
| 2012-12-28 | $201.65M | $646.18M | $444.53M | 31.21% |
| 2012-09-28 | $194.45M | $628.74M | $434.29M | 30.93% |
| 2012-06-29 | $185.40M | $599.12M | $413.71M | 30.95% |
| 2012-03-30 | $180.07M | $579.09M | $399.02M | 31.10% |
| 2011-12-30 | $180.35M | $568.82M | $388.47M | 31.71% |
| 2011-09-30 | (m) | (m) | (m) | (m) |
| 2011-07-01 | (m) | (m) | (m) | (m) |
| 2011-04-01 | (m) | (m) | (m) | (m) |
| 2010-12-31 | $173.58M | $533.42M | $359.84M | 32.54% |
| 2010-10-01 | (m) | (m) | (m) | (m) |
| 2010-07-02 | (m) | (m) | (m) | (m) |
| 2010-01-01 | $166.42M | $521.82M | $355.40M | 31.89% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |